Back to Search

DR. BETSY READE LARDER D.O.

D.O.

Internal Medicine Physician

NPI: 1801282710IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

DR.0074852(CO)58.006009(OH)17627C(WY)
Neurocritical Care Physician

Psychiatry & Neurology — Neurocritical Care

Code: 2084A2900X

34.013040(OH)DR.0074852(CO)
Hospitalist Physician

Hospitalist

Code: 208M00000X

34.013040(OH)011696(AZ)

Education

ROCKY VISTA UNIVERSITY COLLEGE OF OSTEOPATHIC MED

Class of 2015

Research & Publications (20)

A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
PMID 19524413·Artif Intell Med·2009
4-observational
Application of artificial neural networks for decision support in medicine.
PMID 19065808·Methods Mol Biol·2008
8-other
Clinical implications of resistance to antiretrovirals: new resistance technologies and interpretations.
PMID 18505183·Antivir Ther·2008
8-other
Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop.
PMID 19195337·Antivir Ther·2008
8-other
Key reports from the XV International HIV Drug Resistance Workshop 2006.
PMID 17503758·Antivir Ther·2007
7-preclinical
The development of artificial neural networks to predict virological response to combination HIV therapy.
PMID 17503743·Antivir Ther·2007
4-observational
The XIVth International HIV Drug Resistance Workshop, Quebec City, Canada, June 2005.
PMID 16964836·Antivir Ther·2006
7-preclinical
Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro.
PMID 16432030·J Gen Virol·2006
8-other
Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial.
PMID 14986258·Clin Infect Dis·2004
3-trial
Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation.
PMID 12610164·J Virol·2003
8-other
Non-parametric methods to predict HIV drug susceptibility phenotype from genotype.
PMID 12939786·Stat Med·2003
8-other
Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks.
PMID 12934180·J Infect Dis·2003
8-other
Modest decreases in NNRTI susceptibility do not influence virological outcome in patients receiving initial NNRTI-containing triple therapy.
PMID 14640386·Antivir Ther·2003
3-trial
Correlation of phenotypic zidovudine resistance with mutational patterns in the reverse transcriptase of human immunodeficiency virus type 1: interpretation of established mutations and characterization of new polymorphisms at codons 208, 211, and 214.
PMID 12499169·Antimicrob Agents Chemother·2003
8-other
Prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients who have rebound in viral load while receiving antiretroviral therapy in the UNAIDS-Drug Access Initiative in Abidjan, Côte d'Ivoire.
PMID 14565606·AIDS·2003
8-other
Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV Drug Access Initiative--Uganda.
PMID 14565608·AIDS·2003
4-observational
Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215.
PMID 12208978·J Virol·2002
8-other
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.
PMID 12050397·J Virol·2002
8-other
Comparative analysis of two commercial phenotypic assays for drug susceptibility testing of human immunodeficiency virus type 1.
PMID 11773089·J Clin Microbiol·2002
4-observational
Interference between D30N and L90M in selection and development of protease inhibitor-resistant human immunodeficiency virus type 1.
PMID 11850252·Antimicrob Agents Chemother·2002
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 5 locations total

Address
234 GOODMAN ST, ML0781
CINCINNATI, OH 45219
Practice locations map

Locations (5)

Practice Location

234 GOODMAN ST, CINCINNATI, OH
(513) 584-4505

Practice Location

1010 THREE SPRINGS BLVD STE 110A, DURANGO, CO
(970) 764-2750

Practice Location

1200 N BEAVER ST, FLAGSTAFF, AZ
(928) 214-2920

Practice Location

10500 MONTGOMERY RD, MONTGOMERY, OH
(513) 865-2246

Practice Location

400 S 15TH ST, WORLAND, WY
(307) 347-3321

Quick Facts

NPI
1801282710
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
7
Locations
5
Years in Practice
11
Publications
20

Are you this provider?

Claim Your Profile